Dr Reddy’s Laboratories (RDY) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Dr. Reddy’s Laboratories has approved the grant of stock options to eligible employees under its 2018 Employee Stock Option Scheme, with 4,820 options available at an exercise price of Rs. 1,274 per share. This move is part of the company’s efforts to incentivize and retain talent, aligning employees’ interests with those of shareholders. The options are set to vest equally over four years.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
